Dexmedetomidine Versus Clonidine in TAP Block

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 10, 2017

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Transversus Abdominis Plane Block
Interventions
DRUG

Dexmedetomidine

patients will receive ultrasound-guided TAP block using 0.3 ml/kg levobupivacaine (0.125%) with a maximum volume of 20 ml each side + 0.5 ug/kg dexmedetomidine Hydrochloride dissolved in 2 ml normal saline (NaCl 0.9%)

DRUG

Clonidine

patients will receive ultrasound-guided TAP block using 0.3 ml/kg levobupivacaine (0.125%) with a maximum volume of 20 ml + 0.5 ug/kg clonidine dissolved in 2 ml normal saline (NaCl 0.9%)

DRUG

Levobupivacaine

patients will receive ultrasound-guided TAP block using 0.3 ml/kg levobupivacaine (0.125%) with a maximum volume of 20 ml + 2 ml normal saline (NaCl 0.9%).

Trial Locations (1)

Unknown

Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03155646 - Dexmedetomidine Versus Clonidine in TAP Block | Biotech Hunter | Biotech Hunter